Rapport Therapeutics, Inc. · NASDAQ:RAPP

Ceesay Abraham sold 2,210 Rapport Therapeutics, Inc. shares (Form 4)

Traded Jul 27, 2026 · Filed Jul 29, 2026

On Jul 27, 2026, Ceesay Abraham (Director, Chief Executive Officer) sold 2,210 Rapport Therapeutics, Inc. shares at an average US$42.11 for US$93,068 under a trading plan, leaving 537,607 shares. Filed Jul 29, 2026 (Form 4).

Sold
2,210 shares
Price
US$42.11 average (US$42.11 to US$42.74)
Value
US$93,068
Holding after
537,607 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 27, 2026Common StockSale2,203US$42.11537,614Direct
Jul 27, 2026Common StockSale7US$42.74537,607Direct

Source

View original at SEC

Related